NVAX
Novavax Inc
Price:  
6.41 
USD
Volume:  
4,816,588.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Novavax EV/EBITDA

574.6%
Upside

As of 2025-06-22, the EV/EBITDA ratio of Novavax Inc (NVAX) is 1.95. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Novavax's latest enterprise value is 1,003.55 mil USD. Novavax's TTM EBITDA according to its financial statements is 514.35 mil USD. Dividing these 2 quantities gives us the above Novavax EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 10.6x - 13.4x 12.1x
Forward P/E multiples 13.9x - 16.6x 15.0x
Fair Price 34.00 - 52.99 43.24
Upside 430.5% - 726.7% 574.6%
6.41 USD
Stock Price
43.24 USD
Fair Price

Novavax EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-06-20 1.95
2025-06-18 1.92
2025-06-17 1.98
2025-06-16 2.15
2025-06-13 2.12
2025-06-12 2.18
2025-06-11 2.17
2025-06-10 2.20
2025-06-09 2.27
2025-06-06 2.28
2025-06-05 2.13
2025-06-04 2.18
2025-06-03 2.22
2025-06-02 2.16
2025-05-30 2.24
2025-05-29 2.20
2025-05-28 2.11
2025-05-27 2.26
2025-05-23 2.22
2025-05-22 2.23
2025-05-21 2.17
2025-05-20 2.35
2025-05-19 2.37
2025-05-16 2.05
2025-05-15 1.91
2025-05-14 1.81
2025-05-13 1.88
2025-05-12 1.93
2025-05-09 1.81
2025-05-08 2.03
2025-05-07 1.81
2025-05-06 1.84
2025-05-05 1.91
2025-05-02 1.95
2025-05-01 1.95
2025-04-30 2.03
2025-04-29 1.95
2025-04-28 2.04
2025-04-25 2.03
2025-04-24 2.16
2025-04-23 2.28
2025-04-22 1.90
2025-04-21 1.83
2025-04-17 1.82
2025-04-16 1.88
2025-04-15 1.94
2025-04-14 1.95
2025-04-11 1.78
2025-04-10 1.64
2025-04-09 2.06